Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07376772 · ClinicalTrials.gov registry record · NA

Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study

A NA study of Multiple Sclerosis (MS) - Relapsing-remitting and Upper Extremity Dysfunction, sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
2
Study locations

NCT07376772 is a NA study of Multiple Sclerosis (MS) - Relapsing-remitting and Upper Extremity Dysfunction that is actively recruiting participants, run by University of Florida. The registered enrollment target is 15 participants, below the 102-participant average among 5 other Multiple Sclerosis (MS) - Relapsing-remitting trials with a reported enrollment target (85% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07376772, a NA study of Multiple Sclerosis (MS) - Relapsing-remitting and Upper Extremity Dysfunction, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
2
Study locations

Study Summary

This pilot mixed-method study will evaluate the feasibility, preliminary efficacy, and user experience of a home-based wearable Focal Vibration Therapy (FVT) intervention for improving upper extremity (UEx) function in people with multiple sclerosis (MS). Fifteen adults with relapsing-remitting MS (PRMS) and self-reported UEx impairments will participate in a 4-week FVT program using MyovoltTM wearable FVT devices applied to arm muscles.

Conditions Studied

Multiple Sclerosis (MS) - Relapsing-remitting Upper Extremity Dysfunction

Interventions

  • DEVICE wearable focal vibration therapy

Study Locations (2)

Florida

  • Norman Fixel Institute for Neurological Diseases - Gainesville
  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2026-03-04
Est. Completion 2026-06-30
Phase NA

Sponsor

University of Florida

1,106 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07376772

The ClinicalTrials.gov registry entry for NCT07376772 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 102-participant average among 5 other Multiple Sclerosis (MS) - Relapsing-remitting trials with a reported enrollment target (85% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Multiple Sclerosis (MS) - Relapsing-remitting appearing as the primary indexed condition, and to 1 intervention - of which wearable focal vibration therapy is the first listed.

NCT07376772 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT07376772 about?

NCT07376772 is a clinical study titled "Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study". This pilot mixed-method study will evaluate the feasibility, preliminary efficacy, and user experience of a home-based wearable Focal Vibration Therapy (FVT) intervention for improving upper extremity (UEx) function in people with multiple sclerosis (MS). Fifteen adults with relapsing-remitting MS (...

What is the current status of trial NCT07376772?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2026-03-04. Estimated completion is 2026-06-30.

What conditions does trial NCT07376772 study?

This clinical trial studies the following conditions: Multiple Sclerosis (MS) - Relapsing-remitting, Upper Extremity Dysfunction.

What interventions are being tested in trial NCT07376772?

The interventions under investigation include: wearable focal vibration therapy (DEVICE).

Who is sponsoring clinical trial NCT07376772?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07376772 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis (MS) - Relapsing-remitting

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Sclerosis (MS) - Relapsing-remitting

All registered trials for this condition

Upper Extremity Dysfunction

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.